2m 2m 2m 2m 2m 2m 2m
IMMIX BIOPHARMA (IMMX)
NASDAQ
$9.90-$0.01 (-0.14%)
Price as of Jun 23, 2026 7:58 PM EDT- $669.2MMarket Cap
- 342.41%1-Year Change
- BiotechnologyIndustry
IMMIX BIOPHARMA (IMMX)
$9.90-$0.01 (-0.14%)
IMMX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $9.91 | ||
Change | +$0.51 (+5.43%) | ||
Open | $9.23 | ||
High | $10.21 | ||
Low | $9.18 | ||
Previous Close | $9.40 | ||
Volume | 1,631,653 | ||
30-Day Average Volume | 1,761,667 | ||
1-Week Change | 13.39% | ||
1-Month Change | 12.87% | ||
1-Year Change | 342.41% | ||
3-Year Change | 279.69% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 71.2M | ||
Total Assets | $95.8M | ||
Market Cap | $669.2M | ||
Enterprise Value | $589.9M | ||
Period: QTR TTM FY | |||
Revenue | $20.0M | ||
Net Income | -$10.1M | ||
Free Cash Flow | -$9.9M | ||
EBIT | -$10.1M | ||
EBITDA | -$10.0M | ||
Net Working Capital | $81.7M | ||
EPS | -$0.18 | ||
Enterprise Value/EBITDA | -59 | ||
Enterprise Value/Revenue | 29 | ||
P/B | 8 | ||
P/E | -52 | ||
PEG | -2 | ||
Price/Free Cash Flow | -68 | ||
Price/Operating Cash Flow | -68 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue